Diabetes - type 1

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Risk Factors
• Symptoms
• Life-Threatening Complicati...
• Diagnosis
• Dietary Goals and Exercise...
• Treatment
• Monitoring Tests
• Long-Term Complications
• Transplantation Procedures...
• Prevention
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights New Continuous Glucose Meter System In 2007, the FDA approved the STS-7 System, which monitors glucose levels every 5 minutes during a 7-day period. The STS-7 System, like other continuous glucose meter systems, is designed to be used in combination with traditional fingerstick tests and meters. It does not replace them. - 3 Comments

Acute mountain sickness

Sep 03, 2008 - Overview

• Definition
• Alternative Names
• Causes, incidence, and risk factors
• Symptoms
• Signs and tests
• Treatment
• Expectations (prognosis)
• Complications
• Calling your health care provider
• Prevention
• References

Illustrations Respiratory system HEALTH GUIDE REFERENCE FROM A.D.A.M Definition Acute mountain sickness is an illness that can affect mountain climbers, hikers, skiers, or travelers who climb too fast. It usually occurs when people rapidly reach a high altitude (typically above 8,000 feet or 2,400 meters).  Alternative Names High altitude cerebral edema; Altitude anoxia; Altitude sickness; Mountain sickness; High altitude pulmonary edema Causes, incidence, and risk factors Acute mountain sickness occurs from the combination of reduced air pressure and a lower concentration of oxygen at high altitude. Symptoms can range from mild to life-threatening, and can affect the nervous system, lungs, muscles, and heart. - 0 Comments

Multiple sclerosis

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• The Autoimmune Disease Proc...
• Symptoms
• Causes
• Risk Factors
• Complications
• Diagnosis
• Treatment
• Drug Treatment
• Other Treatments
• Treating the Complications...
• Lifestyle Changes
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Gender and Multiple Sclerosis (MS) MS is increasingly affecting women, according to research presented at the 2007 annual conference of the American Academy of Neurology. Researchers found that in the 1940s, women were twice as likely as men to be diagnosed with MS. By 2000, women were about four times more likely than men to develop MS. - 1 Comment

Crohn's disease

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Causes
• Symptoms
• Complications
• Risk Factors
• Diagnosis
• Dietary Factors
• Symptom Management
• Medications
• Surgery
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Biologic Drugs

• In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
• As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies. - 0 Comments
  Read More ›

Roundworms

Oct 08, 2008 - Overview

• Signs and Symptoms
• Causes
• Risk Factors
• Diagnosis
• Preventive Care
• Treatment
• Other Considerations
• Supporting Research

HEALTH GUIDE REFERENCE FROM A.D.A.M Roundworms, or nematodes, are parasites that can infect humans, usually by residing in the intestines. Several different species of worm can cause infection, and worms can range in length from 1 millimeter to 1 meter. As with other parasitic diseases, roundworm infections are more common in warm, tropical climates than in cooler, temperate areas of the world. - 0 Comments

High blood pressure

Oct 08, 2008 - In This Report

• Highlights
• Introduction
• Diagnosis
• Causes
• Risk Factors
• Complications
• Symptoms
• Treatment
• Lifestyle Changes
• Medications
• Classes of Medications
• Resources
• References

HEALTH GUIDE REFERENCE FROM A.D.A.M Highlights Drug Approval In 2007, the FDA approved a new type of high blood pressure drug. Aliskiren (Tekturna) blocks renin, a kidney enzyme that is associated with blood pressure regulation. Aliskiren can be taken alone or in combination with other blood pressure drugs, but it should not be used during pregnancy. - 1 Comment